APO Research
Talk to an analyst

APO RESEARCH · REPORT

Viscosupplementation Injection

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.

Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Selected research

Market Outlook & Growth Opportunities

Global Viscosupplementation Injection Market Outlook and Growth Opportunities 2026

30 December 2025191 pages

Choose your research edition.

Industry ResearchViscosupplementation Injection Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Viscosupplementation Injection Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Viscosupplementation Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Viscosupplementation Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Viscosupplementation Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Viscosupplementation is a medical procedure during which lubricating fluid is injected into a joint. Also called hyaluronic acid injections or hyaluronan injections, viscosupplementation is most commonly used to treat symptoms of symptoms of knee osteoarthritis.

Viscosupplementation can significantly reduce pain while improving the mobility and function of the joint to make activities of daily living and even athletic or strenuous exercise less painful.

Viscosupplementation is a procedure that involves injecting hyaluronic acid, a gel-like fluid, directly into the joint. Hyaluronic acid is found naturally in the synovial fluid surrounding the joints to reduce friction during movement. The injection goes into effect by lubricating the joint and assisting the synovial fluid to create more cushion. This works to reduce pain and improve the range of motion or the mobility of the joint.

Read the full market overview

The classification of Viscosupplementation Injection includes Single Injection, Three Injection, Five Injection, and the sales share of Single Injection take about 40%.

Viscosupplementation Injection is widely used in hospitals, clinics and other place. The most proportion of Viscosupplementation Injection used in Hospitals, and the proportion is 55%.

North America is the largest consumption place, with a consumption market share nearly 52%. Following North America, Asia-Pacific is the second largest consumption place with the consumption market share of 28%.

Sanofi, Bioventus, Seikagaku, Anika Therapeutics, LG Chem, Ferring, etc. are the leaders of the industry. Top six company with about 63% market share.

This report provides an overview of the global Viscosupplementation Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Viscosupplementation Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Viscosupplementation Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Viscosupplementation Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Viscosupplementation Injection Segment by Company

Sanofi

Anika Therapeutics

Seikagaku

Zimmer Biomet

Bioventus

Ferring

LG Chem

Freda

Haohai Biological

Shanghai Jingfeng

Viscosupplementation Injection Segment by Type

Single Injection

Three Injection

Five Injection

Viscosupplementation Injection Segment by Application

Hospitals

Clinics

Others

Viscosupplementation Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Viscosupplementation Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Viscosupplementation Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Viscosupplementation Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Viscosupplementation Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Viscosupplementation Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Viscosupplementation Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Viscosupplementation Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Viscosupplementation Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Viscosupplementation Injection industry.

Chapter 3: Detailed analysis of Viscosupplementation Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Viscosupplementation Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Viscosupplementation Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Viscosupplementation Injection Industry Trends Table 2. Viscosupplementation Injection Industry Drivers Table 3. Viscosupplementation Injection Industry Opportunities and Challenges Table 4. Viscosupplementation Injection Industry Restraints Table 5. Global Viscosupplementation Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Viscosupplementation Injection Revenue Share by Company (2021-2026) Table 7. Global Viscosupplementation Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Viscosupplementation Injection Sales Volume Share by Company (2021-2026) Table 9. Global Viscosupplementation Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Viscosupplementation Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Viscosupplementation Injection Key Company Manufacturing Base & Headquarters Table 12. Global Viscosupplementation Injection Company, Product Type & Application Table 13. Global Viscosupplementation Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Viscosupplementation Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Single Injection Table 18. Significant Companies of Three Injection Table 19. Significant Companies of Five Injection Table 20. Global Viscosupplementation Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Viscosupplementation Injection Sales Volume by Type (2021-2026) & (K Units) Table 22. Global Viscosupplementation Injection Sales Volume by Type (2027-2032) & (K Units) Table 23. Global Viscosupplementation Injection Sales Volume Share by Type (2021-2026) Table 24. Global Viscosupplementation Injection Sales Volume Share by Type (2027-2032) Table 25. Global Viscosupplementation Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Viscosupplementation Injection Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Viscosupplementation Injection Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Viscosupplementation Injection Sales Value Share by Type (2021-2026) Table 29. Global Viscosupplementation Injection Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Others Table 33. Global Viscosupplementation Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Viscosupplementation Injection Sales Volume by Application (2021-2026) & (K Units) Table 35. Global Viscosupplementation Injection Sales Volume by Application (2027-2032) & (K Units) Table 36. Global Viscosupplementation Injection Sales Volume Share by Application (2021-2026) Table 37. Global Viscosupplementation Injection Sales Volume Share by Application (2027-2032) Table 38. Global Viscosupplementation Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Viscosupplementation Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Viscosupplementation Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Viscosupplementation Injection Sales Value Share by Application (2021-2026) Table 42. Global Viscosupplementation Injection Sales Value Share by Application (2027-2032) Table 43. Global Viscosupplementation Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Viscosupplementation Injection Sales by Region (2021-2026) & (K Units) Table 45. Global Viscosupplementation Injection Sales Market Share by Region (2021-2026) Table 46. Global Viscosupplementation Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Viscosupplementation Injection Sales Market Share by Region (2027-2032) Table 48. Global Viscosupplementation Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Viscosupplementation Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Viscosupplementation Injection Sales Value Share by Region (2021-2026) Table 51. Global Viscosupplementation Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Viscosupplementation Injection Sales Value Share by Region (2027-2032) Table 53. Global Viscosupplementation Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Viscosupplementation Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Viscosupplementation Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Global Viscosupplementation Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Viscosupplementation Injection Sales by Country (2021-2026) & (K Units) Table 58. Global Viscosupplementation Injection Sales Market Share by Country (2021-2026) Table 59. Global Viscosupplementation Injection Sales by Country (2027-2032) & (K Units) Table 60. Global Viscosupplementation Injection Sales Market Share by Country (2027-2032) Table 61. Global Viscosupplementation Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Viscosupplementation Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Viscosupplementation Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Viscosupplementation Injection Sales Value Market Share by Country (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Sanofi Viscosupplementation Injection Product Portfolio Table 69. Sanofi Recent Development Table 70. Anika Therapeutics Company Information Table 71. Anika Therapeutics Business Overview Table 72. Anika Therapeutics Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Anika Therapeutics Viscosupplementation Injection Product Portfolio Table 74. Anika Therapeutics Recent Development Table 75. Seikagaku Company Information Table 76. Seikagaku Business Overview Table 77. Seikagaku Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Seikagaku Viscosupplementation Injection Product Portfolio Table 79. Seikagaku Recent Development Table 80. Zimmer Biomet Company Information Table 81. Zimmer Biomet Business Overview Table 82. Zimmer Biomet Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Zimmer Biomet Viscosupplementation Injection Product Portfolio Table 84. Zimmer Biomet Recent Development Table 85. Bioventus Company Information Table 86. Bioventus Business Overview Table 87. Bioventus Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Bioventus Viscosupplementation Injection Product Portfolio Table 89. Bioventus Recent Development Table 90. Ferring Company Information Table 91. Ferring Business Overview Table 92. Ferring Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Ferring Viscosupplementation Injection Product Portfolio Table 94. Ferring Recent Development Table 95. LG Chem Company Information Table 96. LG Chem Business Overview Table 97. LG Chem Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. LG Chem Viscosupplementation Injection Product Portfolio Table 99. LG Chem Recent Development Table 100. Freda Company Information Table 101. Freda Business Overview Table 102. Freda Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Freda Viscosupplementation Injection Product Portfolio Table 104. Freda Recent Development Table 105. Haohai Biological Company Information Table 106. Haohai Biological Business Overview Table 107. Haohai Biological Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Haohai Biological Viscosupplementation Injection Product Portfolio Table 109. Haohai Biological Recent Development Table 110. Shanghai Jingfeng Company Information Table 111. Shanghai Jingfeng Business Overview Table 112. Shanghai Jingfeng Viscosupplementation Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Shanghai Jingfeng Viscosupplementation Injection Product Portfolio Table 114. Shanghai Jingfeng Recent Development Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Viscosupplementation Injection Distributors List Table 118. Viscosupplementation Injection Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Viscosupplementation Injection Product Image Figure 2. Global Viscosupplementation Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Viscosupplementation Injection Sales (2021-2032) & (K Units) Figure 5. Global Viscosupplementation Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Viscosupplementation Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Single Injection Image Figure 10. Three Injection Image Figure 11. Five Injection Image Figure 12. Global Viscosupplementation Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Viscosupplementation Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Viscosupplementation Injection Sales Volume Share by Type (2021-2032) Figure 15. Global Viscosupplementation Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Viscosupplementation Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Viscosupplementation Injection Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Others Image Figure 21. Global Viscosupplementation Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Viscosupplementation Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Viscosupplementation Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Viscosupplementation Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Viscosupplementation Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Viscosupplementation Injection Sales Value Share by Application (2021-2032) Figure 27. Global Viscosupplementation Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 28. Global Viscosupplementation Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Viscosupplementation Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Viscosupplementation Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Viscosupplementation Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Viscosupplementation Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Viscosupplementation Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Viscosupplementation Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Viscosupplementation Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Viscosupplementation Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Viscosupplementation Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Viscosupplementation Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Viscosupplementation Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Single Injection
  • Three Injection
  • Five Injection
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Sanofi
  • Anika Therapeutics
  • Seikagaku
  • Zimmer Biomet
  • Bioventus
  • Ferring
  • LG Chem
  • Freda
  • Haohai Biological
  • Shanghai Jingfeng

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Viscosupplementation Injection Sales Value (2021-2032)
  4. 1.2.2 Global Viscosupplementation Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Viscosupplementation Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Viscosupplementation Injection Market Dynamics
  1. 2.1 Viscosupplementation Injection Industry Trends
  2. 2.2 Viscosupplementation Injection Industry Drivers
  3. 2.3 Viscosupplementation Injection Industry Opportunities and Challenges
  4. 2.4 Viscosupplementation Injection Industry Restraints
3 Viscosupplementation Injection Market by Company
  1. 3.1 Global Viscosupplementation Injection Company Revenue Ranking in 2025
  2. 3.2 Global Viscosupplementation Injection Revenue by Company (2021-2026)
  3. 3.3 Global Viscosupplementation Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Viscosupplementation Injection Average Price by Company (2021-2026)
  5. 3.5 Global Viscosupplementation Injection Company Ranking (2024-2026)
  6. 3.6 Global Viscosupplementation Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Viscosupplementation Injection Company Product Type and Application
  8. 3.8 Global Viscosupplementation Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Viscosupplementation Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Viscosupplementation Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Viscosupplementation Injection Market by Type
  1. 4.1 Viscosupplementation Injection Type Introduction
  2. 4.1.1 Single Injection
  3. 4.1.2 Three Injection
  4. 4.1.3 Five Injection
  5. 4.2 Global Viscosupplementation Injection Sales Volume by Type
  6. 4.2.1 Global Viscosupplementation Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Viscosupplementation Injection Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Viscosupplementation Injection Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Viscosupplementation Injection Sales Value by Type
  10. 4.3.1 Global Viscosupplementation Injection Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Viscosupplementation Injection Sales Value by Type (2021-2032)
  12. 4.3.3 Global Viscosupplementation Injection Sales Value Share by Type (2021-2032)
5 Viscosupplementation Injection Market by Application
  1. 5.1 Viscosupplementation Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Viscosupplementation Injection Sales Volume by Application
  6. 5.2.1 Global Viscosupplementation Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Viscosupplementation Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Viscosupplementation Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Viscosupplementation Injection Sales Value by Application
  10. 5.3.1 Global Viscosupplementation Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Viscosupplementation Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Viscosupplementation Injection Sales Value Share by Application (2021-2032)
6 Viscosupplementation Injection Regional Sales and Value Analysis
  1. 6.1 Global Viscosupplementation Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Viscosupplementation Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Viscosupplementation Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Viscosupplementation Injection Sales by Region (2027-2032)
  5. 6.3 Global Viscosupplementation Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Viscosupplementation Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Viscosupplementation Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Viscosupplementation Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Viscosupplementation Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Viscosupplementation Injection Sales Value (2021-2032)
  12. 6.6.2 North America Viscosupplementation Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Viscosupplementation Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Viscosupplementation Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Viscosupplementation Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Viscosupplementation Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Viscosupplementation Injection Sales Value (2021-2032)
  21. 6.9.2 South America Viscosupplementation Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Viscosupplementation Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Viscosupplementation Injection Sales Value Share by Country, 2025 VS 2032
7 Viscosupplementation Injection Country-level Sales and Value Analysis
  1. 7.1 Global Viscosupplementation Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Viscosupplementation Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Viscosupplementation Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Viscosupplementation Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Viscosupplementation Injection Sales by Country (2027-2032)
  6. 7.4 Global Viscosupplementation Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Viscosupplementation Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Viscosupplementation Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Viscosupplementation Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Viscosupplementation Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Viscosupplementation Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Viscosupplementation Injection Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Anika Therapeutics
  8. 8.2.1 Anika Therapeutics Company Information
  9. 8.2.2 Anika Therapeutics Business Overview
  10. 8.2.3 Anika Therapeutics Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Anika Therapeutics Viscosupplementation Injection Product Portfolio
  12. 8.2.5 Anika Therapeutics Recent Developments
  13. 8.3 Seikagaku
  14. 8.3.1 Seikagaku Company Information
  15. 8.3.2 Seikagaku Business Overview
  16. 8.3.3 Seikagaku Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Seikagaku Viscosupplementation Injection Product Portfolio
  18. 8.3.5 Seikagaku Recent Developments
  19. 8.4 Zimmer Biomet
  20. 8.4.1 Zimmer Biomet Company Information
  21. 8.4.2 Zimmer Biomet Business Overview
  22. 8.4.3 Zimmer Biomet Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Zimmer Biomet Viscosupplementation Injection Product Portfolio
  24. 8.4.5 Zimmer Biomet Recent Developments
  25. 8.5 Bioventus
  26. 8.5.1 Bioventus Company Information
  27. 8.5.2 Bioventus Business Overview
  28. 8.5.3 Bioventus Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Bioventus Viscosupplementation Injection Product Portfolio
  30. 8.5.5 Bioventus Recent Developments
  31. 8.6 Ferring
  32. 8.6.1 Ferring Company Information
  33. 8.6.2 Ferring Business Overview
  34. 8.6.3 Ferring Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ferring Viscosupplementation Injection Product Portfolio
  36. 8.6.5 Ferring Recent Developments
  37. 8.7 LG Chem
  38. 8.7.1 LG Chem Company Information
  39. 8.7.2 LG Chem Business Overview
  40. 8.7.3 LG Chem Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 LG Chem Viscosupplementation Injection Product Portfolio
  42. 8.7.5 LG Chem Recent Developments
  43. 8.8 Freda
  44. 8.8.1 Freda Company Information
  45. 8.8.2 Freda Business Overview
  46. 8.8.3 Freda Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Freda Viscosupplementation Injection Product Portfolio
  48. 8.8.5 Freda Recent Developments
  49. 8.9 Haohai Biological
  50. 8.9.1 Haohai Biological Company Information
  51. 8.9.2 Haohai Biological Business Overview
  52. 8.9.3 Haohai Biological Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Haohai Biological Viscosupplementation Injection Product Portfolio
  54. 8.9.5 Haohai Biological Recent Developments
  55. 8.10 Shanghai Jingfeng
  56. 8.10.1 Shanghai Jingfeng Company Information
  57. 8.10.2 Shanghai Jingfeng Business Overview
  58. 8.10.3 Shanghai Jingfeng Viscosupplementation Injection Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Jingfeng Viscosupplementation Injection Product Portfolio
  60. 8.10.5 Shanghai Jingfeng Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Viscosupplementation Injection Value Chain Analysis
  2. 9.1.1 Viscosupplementation Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Viscosupplementation Injection Sales Mode & Process
  6. 9.2 Viscosupplementation Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Viscosupplementation Injection Distributors
  9. 9.2.3 Viscosupplementation Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst